Name: Peyman Arasteh

Country: Iran, Islamic Republic of

Affiliation:

Shiraz University of Medical Sciences.

Email: Send an Email


Address:

Setad street, Shiraz, Iran.

Research Interests:

  • Surgical oncology
  • Breast cancers
  • Cancer epidemiology and risk factors
  • Cancer clinicopathology

Biography:

  • I Dr. Peyman Arasteh have completed my MD. at Shiraz University of Medical Sciences, and my Masters in Public Health (M.P.H.) training at the same institution. 
  • I have multiple editorial board memberships and have more than 40 authored manuscripts published or in press in high impact journals.
  • I am interested in reconstructive and therapeutic surgical oncology and the design of evidence based studies. Currently I am focusing on establishing and studying the pathophysiology and clinicopathological characteristics of breast cancers.

Publications:

  1. Ghahramani L, Minaie MR, Arasteh P, Hosseini SV, Izadpanah A, Bananzadeh AM, et al. Antibiotic therapy for prevention of fistula in-ano after incision and drainage of simple perianal abscess: A randomized single blind clinical trial. Surgery. 2017. 
  2. Babai MA, Arasteh P, Hadibarhaghtalab M, et al. Defining a BMI Cut-Off Point for the Iranian Population: The Shiraz Heart Study. PloSone. 2016; 11(8):e0160639.
  3. Khalili H, Paydar S, safari R, Arasteh P*, Niakan A, Abolhasani Foroughi A, An
  4. experience with traumatic brain injury: is early tracheostomy associated with better prognosis?, World Neurosurgery (2017), doi: 10.1016/j.wneu.2017.02.060.
  5. Saed D, Arasteh P. Paradoxical thromboembolism despite prophylactic antithrombotic therapy in atrial fibrillation: A case report. International journal of cardiology. Jan 15 2016;203:338-340.
  6. Majid Akrami, Peyman Arasteh*, Maral Mokhtari, Sedigheh Tahmasebi, Vahid Zangouri, Sara Hosseini & Abdolrasoul Talei. Does metaplastic breast carcinoma demonstrate a different clinicopathological behavior in our region: The Shiraz Breast Cancer Registry, accepted for publication at journal of "the Breast".
  7. Amin Abolhasani Foroughi, Ehsan Yazdanpanah, Masoume Nazeri, Tannaz Eghbali, Peyman Arasteh, Ali Ariafar., World J Urol (2018). https://doi.org/10.1007/s00345-018-2528-8
  8. Akrami M, Sepahdar A, Arasteh P, Tahmasebi S, Zangouri V, Askari A, et al. Do site and type of metastasis in breast cancer show a changing pattern with increased age? A cross comparison of clinicopathological characteristics between age groups. World journal of surgical oncology. 2018;16(1):147.
  9. Akrami M, Arasteh P, Eghbali T*, Shahraki HR, Tahmasebi S, Zangouri V, et al. Introducing novel and comprehensive models for predicting recurrence in breast cancer using the group LASSO approach: are estimates of early and late recurrence different? World Journal of Surgical Oncology. 2018;16(1):185.
  10. Article entitled: "The Shiraz Breast Cancer Registry (SBCR): study design and primary reports" accepted for publication by the journal pf Personalized medicine
  11. Zahir ST, NazemianYazdi M, Arasteh P, Mortazavizadeh M, Karbalaeian M, ZareMehrjardi M. Clinicopathological Features and Survival Rate of Colorectal Adenocarcinoma Patients with and without a KRAS Mutation: a FiveYear Study in Yazd, Iran. Asian Pacific journal of cancer prevention: APJCP. 2016; 17(7):3417-3422.